NYSE$IQV

IQVIA Holdings Inc. · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

IQVIA's second-quarter results exceeded expectations amidst the COVID-19 situation, with revenue at $2,521 million and adjusted diluted earnings per share at $1.18.

IQVIA reported second-quarter revenue of $2,521 million and adjusted EBITDA of $483 million. The company's R&D Solutions backlog grew 13.5% year-over-year to $20.5 billion. Due to better than expected performance, the company raised its full-year 2020 guidance for revenue, adjusted EBITDA and adjusted diluted earnings per share.

  • Second quarter revenue was $2,521 million and Adjusted EBITDA was $483 million.
  • GAAP Diluted Earnings per Share was $(0.12) and Adjusted Diluted Earnings per Share was $1.18.
  • R&D Solutions quarterly net book-to-bill ratio was 1.64x including pass throughs and 1.60x excluding pass throughs.
  • R&D Solutions contracted backlog including pass throughs grew 13.5 percent year-over-year to $20.5 billion.

Headline financials

Total Revenue

$2.52B

Previous: $2.74B-8.0%
EPS (adj)

$1.18

Previous: $1.53-22.9%
R&D Solutions contracted backlog

$20.5B

Previous: $18.1B+13.5%
Free Cash Flow

-$23M

Previous: $60M-138.3%
Net Income

-$23M

Previous: $60M-138.3%
Operating Income

$62M

Previous: $197M-68.5%
Gross Profit

$449M

Previous: $941M-52.3%
Cash & Equivalents

$1.11B

Previous: $938M+18.2%
Total Assets

$23.2B

Previous: $23.1B+0.5%
Stock-Based Comp

$36M

Previous: $34M+5.9%

Revenue & EPS history

IQVIA · Revenue · Quarterly

$2.52B

Q2 2020-8%vs Q2 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

IQVIA · $2.52B total across 3 segments · Q2 2020

  • Research & Development Solutions
    $1.24B-13.9%
  • Technology & Analytics Solutions
    $1.11B+0.6%
  • Contract Sales & Medical Solutions
    $177M-12.8%

Forward guidance

The company expects revenue to be between $2,725 million and $2,775 million, Adjusted EBITDA to be between $564 million and $582 million, and Adjusted Diluted Earnings Per Share to be between $1.47 and $1.55 for the third quarter of 2020.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+1.4%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+1.9%

Avg return

30 days after

65%

37 / 57 earnings

Positive

+12.5%

Q2 2018

Best reaction

-10.7%

Q4 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+7.7%+10.9%+13.9%
Q4 2025-10.7%-9.9%-13.8%
Q3 2025+0.3%-0.4%+6.6%
Q2 2025-0.4%+1.1%-1.6%
Q1 2025-4.0%-2.2%-3.2%
Q4 2024+2.2%-2.2%-6.7%
Q3 2024-3.2%-1.5%-7.0%
Q2 2024+6.3%+6.7%+10.0%
Q1 2024-4.1%-1.6%-5.9%
Q4 2023+12.2%+10.8%+17.4%
Q3 2023+5.3%+9.7%+20.0%
Q2 2023-2.1%-3.1%-0.5%
Q1 2023-0.9%-2.3%+5.0%
Q4 2022+0.8%-1.4%-14.4%
Q3 2022+1.4%+6.1%+11.3%
Q2 2022+0.5%-0.4%+8.3%
Q1 2022+6.1%+5.0%+6.7%
Q4 2021-3.2%-4.8%-6.9%
Q3 2021+2.1%+1.8%+6.6%
Q2 2021-0.8%+0.2%+4.5%
Q1 2021+6.1%+7.0%+9.1%
Q4 2020+4.9%+4.8%+1.6%
Q3 2020+3.2%+2.1%+3.4%
Q2 2020+2.9%+3.4%+0.4%
Q1 2020+8.5%+3.5%+10.9%
Q4 2019+2.5%+1.6%-26.6%
Q3 2019-3.8%-2.4%-2.7%
Q2 2019+2.1%+1.6%-2.3%
Q1 2019-2.0%-0.1%-2.2%
Q4 2018+7.6%+7.3%+7.4%
Q3 2018-3.5%-5.3%-8.4%
Q2 2018+12.5%+8.2%+11.7%
Q1 2018-0.7%+0.2%+2.6%
Q4 2017+1.5%+1.7%+5.6%
Q3 2017+6.1%+6.5%+2.7%
Q2 2017-1.3%-1.0%+4.4%
Q1 2017-3.7%-2.0%+3.0%
Q4 2016-2.7%-4.1%+0.5%
Q3 2016+0.8%+4.1%+3.3%
Q2 2016+3.3%+4.2%+0.3%
Q1 2016-5.9%
Q4 2015+3.6%
Q3 2015-6.2%
Q2 2015+2.6%
Q1 2015-4.9%
Q4 2014+4.3%
Q3 2014+0.9%
Q2 2014-3.1%
Q1 2014+0.4%
Q4 2011+7.5%
Q4 2013+7.5%
Q3 2012+0.1%
Q3 2013+0.1%
Q2 2012+0.8%
Q2 2013+0.8%
Q1 2012+5.0%
Q4 2012+5.0%
Q1 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro